Takeda's Response to COVID-19 If you were diagnosed with COVID-19 and have recovered, you may be able to help in furthering research into a potential therapy for others by donating your plasma.

Guided Search

Enter the condition you are interested in

Next

Find a Trial

Click for Guided SearchOpen Guided Search
Condition or Trial Identifier
Location

FILTERS

FILTERS

Clear all

FILTERS

Clear all
Medical Condition / Disease  
Drug / Treatment  
Trial Status  
Age

or Select Age Range:

Trial Type  
Phase  
Trial Identifier  
Results  
Show Results

Results

(1921)
Selected Filters
Recruiting
From 12 years

Hemophilia A

ADYNOVATE Drug Use-Results Survey
5,937 miles (9,555 km) from
Toronto, Ontario
From 12 years
Recruiting
From 18 years

Acquired Hemophilia A

Prospective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life Practice
186 miles (300 km) from
Toronto, Ontario
From 18 years
Recruiting
All Ages

Hemophilia B

RIXUBIS PMS India (RIXUBIS PMS)
7,818 miles (12,583 km) from
Toronto, Ontario
All Ages
Recruiting
Up to 5 years

Hemophilia A

Safety, Immunogenicity and Hemostatic Efficacy of PEGylated Recombinant FVIII (BAX 855) in Previously Untreated Patients (PUPs) < 6 Years of Age With Severe Hemophilia A
38 miles (61 km) from
Toronto, Ontario
Up to 5 years
Recruiting
Up to 18 Years

Primary Immunodeficiencies (PID)

Retrospective, Observational Chart Review Study Conducted in Poland to Document the Management and Clinical Outcome of CUVITRU and HYQVIA in Pediatric Participants (< 18 Years) With Primary Immunodeficiency (PID)
4,135 miles (6,654 km) from
Toronto, Ontario
Up to 18 Years
Recruiting
All Ages

Hemophilia A

ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)
0.33 miles (0.53 km) from
Toronto, Ontario
All Ages
Recruiting
18 - 65 years

Hemophilia A or B with Inhibitors

FEIBA Reconstitution Volume Reduction and Faster Infusion Study (FEIBA STAR)
4,381 miles (7,050 km) from
Toronto, Ontario
18 - 65 years
Recruiting
From 18 years

Chronic inflammatory demyelinating polyradiculoneuropathy

Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP
0.4 miles (0.64 km) from
Toronto, Ontario
From 18 years
Recruiting
All Ages

Gaucher Disease

Gaucher Disease Outcome Survey (GOS)
420 miles (676 km) from
Toronto, Ontario
All Ages
Recruiting
From 18 years

Chronic inflammatory demyelinating polyradiculoneuropathy

Phase III Efficacy, Safety, and Tolerability Study of HYQVIA/HyQvia and GAMMAGARD LIQUID/KIOVIG in CIDP
0.46 miles (0.74 km) from
Toronto, Ontario
From 18 years